#vaccination — Monday, October 12, 2026 (1 items)
| 11 | ℹ |
Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace).
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-10-12 | #vaccination #immunogenicity #sepsis #bacteremia #infection |